Metropolitan Life Insurance Company (MetLife)’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-13,021
| Closed | -$872K | – | 2447 |
|
|
2021
Q4 | $872K | Sell |
13,021
-250
| -2% | -$16.9K | 0.01% | 1060 |
|
|
2021
Q3 | $909K | Sell |
13,271
-175
| -1% | -$12.4K | 0.01% | 1031 |
|
|
2021
Q2 | $918K | Buy |
13,446
+34
| +0.3% | +$2.4K | 0.01% | 1082 |
|
|
2021
Q1 | $927K | Buy |
13,412
+708
| +6% | +$48K | 0.01% | 992 |
|
|
2020
Q4 | $825K | Sell |
12,704
-339
| -3% | -$18.2K | 0.01% | 1019 |
|
|
2020
Q3 | $616K | Sell |
13,043
-628
| -5% | -$29.9K | 0.01% | 1069 |
|
|
2020
Q2 | $642K | Sell |
13,671
-5,298
| -28% | -$260K | 0.01% | 1030 |
|
|
2020
Q1 | $847K | Sell |
18,969
-1,030
| -5% | -$54.1K | 0.02% | 764 |
|
|
2019
Q4 | $1.17M | Buy |
19,999
+192
| +1% | +$11.4K | 0.02% | 806 |
|
|
2019
Q3 | $1.19M | Sell |
19,807
-3,183
| -14% | -$190K | 0.02% | 768 |
|
|
2019
Q2 | $1.28M | Sell |
22,990
-35
| -0.2% | -$1.8K | 0.02% | 756 |
|
|
2019
Q1 | $1.28M | Sell |
23,025
-87
| -0.4% | -$4.43K | 0.02% | 732 |
|
|
2018
Q4 | $1.04M | Buy |
23,112
+49
| +0.2% | +$2.69K | 0.02% | 790 |
|
|
2018
Q3 | $1.52M | Sell |
23,063
-240
| -1% | -$14.9K | 0.03% | 684 |
|
|
2018
Q2 | $1.5M | Buy |
23,303
+3,605
| +18% | +$223K | 0.02% | 695 |
|
|
2018
Q1 | $1.09M | Sell |
19,698
-761
| -4% | -$39.9K | 0.02% | 863 |
|
|
2017
Q4 | $979K | Sell |
20,459
-21,670
| -51% | -$1.06M | 0.01% | 900 |
|
|
2017
Q3 | $2.13M | Buy |
42,129
+337
| +0.8% | +$17.3K | 0.01% | 922 |
|
|
2017
Q2 | $2.28M | Hold |
41,792
| – | – | 0.02% | 909 |
|
|
2017
Q1 | $1.76M | Hold |
41,792
| – | – | 0.01% | 990 |
|
|
2016
Q4 | $1.79M | Sell |
41,792
-694
| -2% | -$28.2K | 0.01% | 1013 |
|
|
2016
Q3 | $1.75M | Sell |
42,486
-668
| -2% | -$28K | 0.01% | 1002 |
|
|
2016
Q2 | $1.72M | Buy |
43,154
+702
| +2% | +$25.3K | 0.01% | 998 |
|
|
2016
Q1 | $1.43M | Buy |
42,452
+3,390
| +9% | +$106K | 0.01% | 1011 |
|
|
2015
Q4 | $1.32M | Hold |
39,062
| – | – | 0.01% | 1043 |
|
|
2015
Q3 | $1.16M | Sell |
39,062
-3,947
| -9% | -$123K | 0.01% | 1117 |
|
|
2015
Q2 | $1.18M | Sell |
43,009
-5,372
| -11% | -$143K | 0.01% | 1181 |
|
|
2015
Q1 | $1.22M | Sell |
48,381
-1,882
| -4% | -$44.5K | 0.01% | 1102 |
|
|
2014
Q4 | $1.11M | Buy |
50,263
+2,001
| +4% | +$40.6K | 0.01% | 1270 |
|
|
2014
Q3 | $979K | Hold |
48,262
| – | – | 0.01% | 1288 |
|
|
2014
Q2 | $928K | Buy |
48,262
+292
| +0.6% | +$5.44K | 0.01% | 1404 |
|
|
2014
Q1 | $902K | Hold |
47,970
| – | – | 0.01% | 1420 |
|
|
2013
Q4 | $935K | Buy |
47,970
+7,028
| +17% | +$129K | 0.01% | 1371 |
|
|
2013
Q3 | $674K | Sell |
40,942
-2,290
| -5% | -$36.7K | 0.01% | 1552 |
|
|
2013
Q2 | $647K | Buy |
+43,232
| New | +$634K | 0.01% | 1523 |
|
Other funds holding IART
CIP
EVM
CB
Metropolitan Life Insurance Company (MetLife)'s IART Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Integra LifeSciences (IART) in Q1 2022, closing a stake of 13,021 shares — an estimated $872K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in IART in Q2 2013 and held it in 35 quarters. The position peaked at $2.28M in Q2 2017. 278 funds tracked by Wall St. Rank hold IART as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Integra LifeSciences position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 13,021 Integra LifeSciences shares in Q1 2022, an estimated $872K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Integra LifeSciences in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Integra LifeSciences position peaked at $2.28M in Q2 2017.
- 278 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.